MS ||| S:0 E:2 ||| NNP
,  ||| S:2 E:4 ||| ,
MRI ||| S:4 E:7 ||| NNP
,  ||| S:7 E:9 ||| ,
and  ||| S:9 E:13 ||| CC
the  ||| S:13 E:17 ||| DT
2010  ||| S:17 E:22 ||| CD
McDonald  ||| S:22 E:31 ||| NN
criteria ||| S:31 E:39 ||| NNS
:  ||| S:39 E:41 ||| :
a  ||| S:41 E:43 ||| DT
Canadian  ||| S:43 E:52 ||| JJ
expert  ||| S:52 E:59 ||| NN
commentary  ||| S:59 E:70 ||| NN
Since  ||| S:70 E:76 ||| IN
the  ||| S:76 E:80 ||| DT
first  ||| S:80 E:86 ||| JJ
development  ||| S:86 E:98 ||| NN
of  ||| S:98 E:101 ||| IN
diagnostic  ||| S:101 E:112 ||| JJ
criteria  ||| S:112 E:121 ||| NNS
for  ||| S:121 E:125 ||| IN
multiple  ||| S:125 E:134 ||| JJ
sclerosis  ||| S:134 E:144 ||| NNS
( ||| S:144 E:145 ||| -LRB-
MS ||| S:145 E:147 ||| NNP
) ||| S:147 E:148 ||| -RRB-
,  ||| S:148 E:150 ||| ,
there  ||| S:150 E:156 ||| EX
have  ||| S:156 E:161 ||| VBP
been  ||| S:161 E:166 ||| VBN
regular  ||| S:166 E:174 ||| JJ
revisions  ||| S:174 E:184 ||| NNS
of  ||| S:184 E:187 ||| IN
disease  ||| S:187 E:195 ||| NN
definitions  ||| S:195 E:207 ||| NNS
and  ||| S:207 E:211 ||| CC
diagnostic  ||| S:211 E:222 ||| JJ
thresholds  ||| S:222 E:233 ||| NNS
aimed  ||| S:233 E:239 ||| VBN
at  ||| S:239 E:242 ||| IN
improving  ||| S:242 E:252 ||| VBG
specificity  ||| S:252 E:264 ||| NN
while  ||| S:264 E:270 ||| IN
maintaining  ||| S:270 E:282 ||| VBG
sensitivity ||| S:282 E:293 ||| NN
.  ||| S:293 E:295 ||| .
The  ||| S:295 E:299 ||| DT
central  ||| S:299 E:307 ||| JJ
requirements  ||| S:307 E:320 ||| NNS
for  ||| S:320 E:324 ||| IN
diagnosis  ||| S:324 E:334 ||| NN
of  ||| S:334 E:337 ||| IN
MS  ||| S:337 E:340 ||| NNP
are  ||| S:340 E:344 ||| VBP
dissemination  ||| S:344 E:358 ||| VBN
in  ||| S:358 E:361 ||| IN
space  ||| S:361 E:367 ||| NN
( ||| S:367 E:368 ||| -LRB-
DIS ||| S:368 E:371 ||| NNP
)  ||| S:371 E:373 ||| -RRB-
and  ||| S:373 E:377 ||| CC
dissemination  ||| S:377 E:391 ||| NN
in  ||| S:391 E:394 ||| IN
time  ||| S:394 E:399 ||| NN
( ||| S:399 E:400 ||| -LRB-
DIT ||| S:400 E:403 ||| NNP
)  ||| S:403 E:405 ||| -RRB-
of  ||| S:405 E:408 ||| IN
lesions  ||| S:408 E:416 ||| NNS
in  ||| S:416 E:419 ||| IN
the  ||| S:419 E:423 ||| DT
CNS ||| S:423 E:426 ||| NNP
,  ||| S:426 E:428 ||| ,
with  ||| S:428 E:433 ||| IN
the  ||| S:433 E:437 ||| DT
proviso  ||| S:437 E:445 ||| NN
that  ||| S:445 E:450 ||| IN
there  ||| S:450 E:456 ||| EX
should  ||| S:456 E:463 ||| MD
be  ||| S:463 E:466 ||| VB
no  ||| S:466 E:469 ||| DT
alternate  ||| S:469 E:479 ||| JJ
diagnosis  ||| S:479 E:489 ||| NN
that  ||| S:489 E:494 ||| WDT
better  ||| S:494 E:501 ||| RB
explains  ||| S:501 E:510 ||| VBZ
the  ||| S:510 E:514 ||| DT
clinical  ||| S:514 E:523 ||| JJ
presentation ||| S:523 E:535 ||| NN
.  ||| S:535 E:537 ||| .
The  ||| S:537 E:541 ||| DT
most  ||| S:541 E:546 ||| RBS
definitive  ||| S:546 E:557 ||| JJ
diagnosis  ||| S:557 E:567 ||| NN
is  ||| S:567 E:570 ||| VBZ
the  ||| S:570 E:574 ||| DT
purely  ||| S:574 E:581 ||| JJ
clinical  ||| S:581 E:590 ||| JJ
one ||| S:590 E:593 ||| CD
,  ||| S:593 E:595 ||| ,
with  ||| S:595 E:600 ||| IN
2  ||| S:600 E:602 ||| CD
separate  ||| S:602 E:611 ||| JJ
attacks  ||| S:611 E:619 ||| NNS
of  ||| S:619 E:622 ||| IN
symptoms  ||| S:622 E:631 ||| NNS
( ||| S:631 E:632 ||| -LRB-
fulfilling  ||| S:632 E:643 ||| FW
DIT  ||| S:643 E:647 ||| FW
criteria ||| S:647 E:655 ||| FW
)  ||| S:655 E:657 ||| -RRB-
involving  ||| S:657 E:667 ||| VBG
at  ||| S:667 E:670 ||| IN
least  ||| S:670 E:676 ||| JJS
2  ||| S:676 E:678 ||| CD
different  ||| S:678 E:688 ||| JJ
areas  ||| S:688 E:694 ||| NNS
of  ||| S:694 E:697 ||| IN
the  ||| S:697 E:701 ||| DT
CNS  ||| S:701 E:705 ||| NNP
( ||| S:705 E:706 ||| -LRB-
fulfilling  ||| S:706 E:717 ||| FW
DIS  ||| S:717 E:721 ||| FW
criteria ||| S:721 E:729 ||| FW
) ||| S:729 E:730 ||| -RRB-
.  ||| S:730 E:732 ||| .
In  ||| S:732 E:735 ||| IN
patients  ||| S:735 E:744 ||| NNS
who  ||| S:744 E:748 ||| WP
have  ||| S:748 E:753 ||| VBP
had  ||| S:753 E:757 ||| VBN
a  ||| S:757 E:759 ||| DT
first  ||| S:759 E:765 ||| JJ
but  ||| S:765 E:769 ||| CC
not  ||| S:769 E:773 ||| RB
a  ||| S:773 E:775 ||| DT
second  ||| S:775 E:782 ||| JJ
clinical  ||| S:782 E:791 ||| JJ
attack ||| S:791 E:797 ||| NN
,  ||| S:797 E:799 ||| ,
the  ||| S:799 E:803 ||| DT
McDonald  ||| S:803 E:812 ||| NN
criteria  ||| S:812 E:821 ||| NNS
provide  ||| S:821 E:829 ||| VBP
guidance  ||| S:829 E:838 ||| VBN
on  ||| S:838 E:841 ||| IN
how  ||| S:841 E:845 ||| WRB
paraclinical  ||| S:845 E:858 ||| JJ
evidence  ||| S:858 E:867 ||| NN
can  ||| S:867 E:871 ||| MD
be  ||| S:871 E:874 ||| VB
used  ||| S:874 E:879 ||| VBN
to  ||| S:879 E:882 ||| TO
support  ||| S:882 E:890 ||| VB
a  ||| S:890 E:892 ||| DT
diagnosis  ||| S:892 E:902 ||| NN
of  ||| S:902 E:905 ||| IN
MS ||| S:905 E:907 ||| NNP
.  ||| S:907 E:909 ||| .
Recently ||| S:909 E:917 ||| RB
,  ||| S:917 E:919 ||| ,
the  ||| S:919 E:923 ||| DT
McDonald  ||| S:923 E:932 ||| NN
criteria  ||| S:932 E:941 ||| NNS
were  ||| S:941 E:946 ||| VBD
revised  ||| S:946 E:954 ||| VBN
and  ||| S:954 E:958 ||| CC
new  ||| S:958 E:962 ||| JJ
definitions  ||| S:962 E:974 ||| NNS
for  ||| S:974 E:978 ||| IN
DIS  ||| S:978 E:982 ||| NNP
and  ||| S:982 E:986 ||| CC
DIT  ||| S:986 E:990 ||| NNP
proposed ||| S:990 E:998 ||| VBD
.  ||| S:998 E:1000 ||| .
In  ||| S:1000 E:1003 ||| IN
response  ||| S:1003 E:1012 ||| NN
to  ||| S:1012 E:1015 ||| TO
that  ||| S:1015 E:1020 ||| DT
revision ||| S:1020 E:1028 ||| NN
,  ||| S:1028 E:1030 ||| ,
a  ||| S:1030 E:1032 ||| DT
panel  ||| S:1032 E:1038 ||| NN
of  ||| S:1038 E:1041 ||| IN
Canadian  ||| S:1041 E:1050 ||| NNP
MS  ||| S:1050 E:1053 ||| NNP
neurologists  ||| S:1053 E:1066 ||| NNS
and  ||| S:1066 E:1070 ||| CC
one  ||| S:1070 E:1074 ||| CD
neuroradiologist  ||| S:1074 E:1091 ||| NNS
created  ||| S:1091 E:1099 ||| VBD
this  ||| S:1099 E:1104 ||| DT
commentary  ||| S:1104 E:1115 ||| NN
regarding  ||| S:1115 E:1125 ||| VBG
the  ||| S:1125 E:1129 ||| DT
clinical  ||| S:1129 E:1138 ||| JJ
implications  ||| S:1138 E:1151 ||| NNS
and  ||| S:1151 E:1155 ||| CC
applications  ||| S:1155 E:1168 ||| NNS
of  ||| S:1168 E:1171 ||| IN
the  ||| S:1171 E:1175 ||| DT
2010  ||| S:1175 E:1180 ||| CD
McDonald  ||| S:1180 E:1189 ||| NN
criteria ||| S:1189 E:1197 ||| NNS
.  ||| S:1197 E:1199 ||| .
